Your primary issue was management not caring for SH's. Management has produced something that is beneficial to SH's.
So now you revert back to one of your secondary issues. That PAB doesn't have 'much more data' etc. with a kicker of 'if we had 20 bio's step forward'.
Needing more data and not having 20 bio's knocking the door down is reflective in the share price.
You have purchased a bio stock for pennies and you are taken aback that there is not more data and that it's not moving quick enough?
Do you think that maybe you need to manage your own expectations and patience?
Was it and is it still risky - why yes, it is. Risky means the share price has a high chance of going down.
High risk, high reward also.
2020, page-113
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 5492487 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1636778 | 2 |
View Market Depth
| Last trade - 10.19am 10/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable